Popular Articles

House Democrats May Rethink Tax Increases
Democratic leaders may scale back a plan to tax the highest American earners, The New York Times reports.

FDA Approves First Canine Cancer Therapy
Pfizer Animal Health today announced that the U.S. Food and Drug Administration (FDA) has approved the first canine cancer therapy in the U.S. - PALLADIATM (toceranib phosphate) - which was developed by Pfizer to treat mast cell tumors in dogs. Pfizer made the announcement to veterinarians attending the 2009 American College of Veterinary Internal Medicine (ACVIM) Forum and Canadian Veterinary Medical Association Convention.
News of the day
Development Of DNA Drugs Gives Hope To Lupus Patients
A generation of DNA-like compounds, class R inhibitory oligonucleotides (INH-ODNs), have been shown to effectively inhibit cells responsible for the chronic autoimmune condition lupus. Researchers writing in BioMed Central"s open access journal Arthritis Research & Therapy have demonstrated the anti-inflammatory effects of the INH-ODNs in both in vitro and mouse experiments.
Oncology

Medical Website Design Company Aurora Information Technology, Inc. Introduces The New Ovu-Trac(R) Website

Aurora Information Technology (Aurora IT), a developer of highly customized medical website designs, introduces the launch of the new Ovu-Trac® site (http://www.ovu-trac.com). Created with Bitrix Site Manager, the Ovu-Trac® website is an informational and educational portal that markets its signature product, the Ovu-Trac® Ovulation Predictor Kit. Manufactured by OvumOptics, Inc., the kit uses saliva to accurately identify fertility and ovulation. Customers can purchase the kit through the site"s Fertilit-eStore and read testimonials from customers who have used the product. The site also features market comparisons, product background and scientific research behind the concept of saliva testing for predicting ovulation. Colleen Biggs, President and Founder of OvumOptics, Inc., stands behind the integrity of her product with a special section under Quality Commitment. This fertility predictor has been used successfully by tens of thousands of women throughout Canada, and has recently passed Food and Drug Administration requirements for legal sale in the United States. Both Health Canada and the Food and Drug Administration in the United States consider the kit an in-vitro diagnostic medical device. Both government agencies have stringent regulations that medical device manufacturers and distributors must meet to legally sell their products to the public. With the comprehensive information available on this site, customers can make informed, confident decisions prior to purchasing with the Ovu-Trac® Ovulation Predictor Kit. Aurora IT designs, develops, and launches customized websites and online medical marketing campaigns focused on developing brand awareness: "Before I contracted Aurora IT to complete our new Ovu-Trac® medical device website, I spent several weeks researching web design and successful internet marketing strategies. I wanted to understand what qualities to look for when contracting these services so that our new website would be focused at our target market and rank high in the search engines. After screening several companies, Aurora IT proved to be the most qualified - they were professional, creative and proactive in their approach to designing our site and involved us in every step of the process. I am very pleased with their work to date and feel confident that their marketing services will play a pivotal role in the future success of our business." - Colleen Biggs, President, OvumOptics, Inc. With a focus on being creatively strategic, the Ovu-Trac® site is unique and content-rich, which is just what their customer needs. Aurora IT has presented the Ovu-Trac® site in a way that leverages quality over quantity. Aurora Information Technology


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):